The slow afterhyperpolarization (sIAHP) is a Ca2+-dependent K+ current that regulates hippocampal neuronal firing properties. The sIAHP is responsible for accommodation of action potential firing during bursts of activity. Although the effects of the sIAHP on cell firing properties is well characterised its effect on the behaviour of an oscillating network is unclear. The influence of the sIAHP on gamma frequency oscillations (30-80 Hz) was investigated using mouse hippocampal slices.
All animals were humanely killed. Male adult mice were anaesthetised with inhaled isoflurane prior to intramuscular injection of ketamine (²ge³ 100 mg kg-1) and xylazine (²ge³ 10 mg kg-1). When all responses to noxious stimuli had terminated the animals were intracardially perfused with ~25 ml of modified artificial cerebrospinal fluid (ACSF) in which 126 mM NaCl was replaced with equiosmolar sucrose. Gamma frequency oscillations were induced by bath application of kainate (50-200 nM). Extracellular recordings were made from stratum radiatum/lacunosum-moleculare in the CA3 region. The power of the oscillation (the area from the power spectrum between 20-80 Hz) is expressed as mean percentage change ± S.E.M. Statistical significance was tested using either a paired t test or signed rank test.
The L-type calcium channel antagonist, nifedipine (10 µM), was bath applied to the established kainate-induced oscillation to decrease the sIAHP. Nifedipine caused a trend to gradually increase the power of the gamma frequency oscillation, although this was not significant. After 15, 30 and 45 min application of nifedipine the power increased by 55 ± 28.3 % (n = 12; P > 0.05), 79 ± 23.7 % (n = 12; P > 0.05), and 101 ± 36.6 % (n = 10; P > 0.05) respectively. The frequency of the oscillation showed a significant reduction of 5 ± 2.6 % (n = 12; P < 0.05) after 30 min. The L-type calcium channel agonist, Bay K 8644 (1 µM) was bath applied to the established kainate-induced oscillation to increase the sIAHP. After 15 min application there was a significant decrease in the power of the gamma frequency oscillation of 23 ± 5.1 % (n = 8; P < 0.01). A further significant decrease in power of 53 ± 6.5 % (n = 8; P < 0.01) was seen after 30 min application. However, there was no significant change in the frequency of the oscillation (P > 0.05).
These results suggest that modulation of the sIAHP can affect kainate-induced gamma frequency activity. In particular the L-type calcium channel agonist Bay K 8644 significantly disrupted gamma oscillations. These results suggest that the sIAHP has a direct effect on the behaviour of an oscillating network.
This work was supported by the MRC and Wellcome Trust.